Announcements

  • Frontotemporal deterioration leads to early-onset dementia.

    The first clinical results in patients with a genetic form of frontotemporal dementia show that enhancing progranulin in the brain may halt disease progression.

  • Podcast logo of a black field with a grey old school microphone and two speech bubbles, the Nature Biotechnology logo at upper left and "From Bench to Podcast: Stories from Biotech Labs" at lower left

    On this episode, Cláudia Vilhena interviews Chloe Fishman, first author of a paper describing a versatile tool using recombitrons for bacteriophage gene editing. They discuss the advantages of this tool over existing methods, the relevance of phage therapy in the fight against antimicrobial resistance, and the crucial role mentorship plays in empowering early career researchers.

  • A pair of CAR-T cells attacking cancerous cells

    From Biopharma Dealmakers: Deals and funding for cell and gene therapy companies have been muted in the past year compared to recent peaks, but emerging technologies that are advancing treatments for autoimmune diseases and in vivo engineering could reinvigorate the field.

Advertisement

Canada’s skyline

Life sciences and biotech in Canada

In this spotlight, we discover more to Canada’s biotech scene by providing an overview of the market landscape and showcasing some of its innovative companies.
Collection

Advertisement

Nature Careers

Science jobs

Advertisement